COMP <GO>
BTSG vs LLY // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
BrightSpring Health Services Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: BTSG 3
— LLY 12
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: BTSG
LAST: $66.89 (+11.08%) • MKT CAP: $11.92B
options-implied-move
6.70%
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
options-implied-move
6.77%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BTSG VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BTSG | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 11.80% | 83.64% | -71.84 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.50% | 32.36% | -26.86 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.9x | 36.4x | +1.48 | LLY | /valuation <GO> |
| Free Cash Flow Yield | 3.31% | 2.30% | +1.01 | BTSG | /fcf-yield <GO> |
| Operating Margin | 2.30% | 40.21% | -37.91 | LLY | /operating-margins <GO> |
| Net Profit Margin | 1.50% | 31.90% | -30.40 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 28.20% | 45.51% | -17.31 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.92 | 9.29 | -5.37 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.70% | 6.77% | -0.07 | BTSG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.3 | 77.9 | -10.62 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 0.51 | +0.43 | BTSG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 52.9x | 26.3x | +26.65 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.92B | $1.33T | -$1.32T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BTSG REV | LLY REV | BTSG GROSS % | LLY GROSS % | BTSG FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $12.91B | $65.18B | 11.8% | 83.0% | $394.7M | $16.81B |
| FY 2024 | $10.07B | $45.04B | 12.6% | 81.3% | -$57.1M | $8.82B |
| FY 2023 | $7.69B | $34.12B | 44.0% | 79.3% | -$135.3M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BTSG // BETA 0.94
LLY // BETA 0.51